Tiziana Life Sciences PLC (TLSA) Stock: Is This Biotech Stock Worth Your Consideration?


Tiziana Life Sciences PLC (TLSA) is working its way for to the bottom in the market today. The company, focused in the biotechnology industry, is presently trading at $5.30 after tumbling -5.36% so far today. As it relates to biotech companies, there are several factors that have the ability to lead to price movement in the market. News is one of the most common reasons for movement. Here are the recent stories associated with TLSA:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-11-18 05:43PM Nasdaq Keeps Momentum, Other Indexes Close Lower Tuesday
Dec-03-18 03:29AM Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)
Nov-28-18 10:24AM Tiziana Announces Initiation of Phase 1 Clinical Trial with Nasal Administration of Foralumab, a Fully Human Anti-Cluster Definition 3 Monoclonal Antibody (anti-CD3 mAb), in Healthy Volunteers
Nov-23-18 12:11PM Tiziana Announces Closing of Offering and Resulting Total Voting Rights
Nov-19-18 07:19PM Tiziana Announces Pricing of Offering and Warrant Conversion Raising in Aggregate $5.79 million of New Equity Capital, Approval to List on the Nasdaq Global Market and Loan Conversion Extinguishing $1.78 million of Debt

Nonetheless, when making a decision with regard to investing, investors should look into far more than news, this is especially the case in the generally speculative biotechnology industry. Here’s what’s happening with Tiziana Life Sciences PLC.

Recent Moves From TLSA

While a move down on a single session, like the move that we’re seeing from Tiziana Life Sciences PLC may cause fear in some investors, that by itself shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It is generally a good idea to look into trends beyond a single session. In the case of TLSA, below are the movements that investors have experienced:

  • Past 7 Days – Over the past 7 days, TLSA has produced a change in value amounting to -8.78%.
  • Past 30 Days – The ROI from Tiziana Life Sciences PLC throughout the past 30 days works out to -4.69%.
  • Quarterly – Over the last three months, the stock has generated a return on investment that comes to 0
  • Past Six Months – Throughout the last 6 months, investors have seen a change that works out to 0 from the stock.
  • Year To Date – Since the the first trading session of this year TLSA has produced a return on investment of -28.86%.
  • Full Year – Lastly, over the past year, investors have seen performance that works out to 0 from TLSA. In this period of time, the stock has sold at a high of -56.45% and a low of 6.00%.

Key Ratios

Digging into various ratios associated with a company can provide investors a look of how risky and/or potentially profitable a pick may be. Below are some of the most important ratios to consider when digging into TLSA.

Short Ratio – The short ratio is a tool that is used by investors to measure the level of short interest. As the ratio climbs, it shows that more investors are expecting that the price of the stock is headed for declines. Throughout the sector, biotech stocks can have a higher short ratio. However, we tend to see a lot of short squeezes in the industry. Nonetheless, when it comes to Tiziana Life Sciences PLC, it’s short ratio is 0.00.

Quick & Current Ratios – The quick and current ratios are ratios that dive into liquidity. Basically, they measure whether or not a company can cover its debts when they come due based on quick assets or current assets. Because many biotech many companies rely heavily on the continuation of support from investors, the quick and current ratios can look bad. However, some good picks in the biotechnology sector do have great quick and current ratios. As it relates to TLSA, the quick and current ratios add up to 0 and 0 respectively.  

Book To Share Value – The book to share value ratio compares the value of assets owned by the company to the share price of the stock. as it relates to Tiziana Life Sciences PLC, that ratio is -0.03.

Cash To Share Value – Finally, the cash to share value ratio compares the amount of cash the company has on hand to the value of shares. Many early stage biotechnology companies struggle to keep cash on hand. So, if you’re interested in a stock in the biotech sector, this is a very important ratio to look into. In the case of TLSA, the cash to share value is 0.

What Analysts Say About Tiziana Life Sciences PLC

While it’s never a smart idea to blindly follow the thoughts of analysts, it is a good idea to use their analysis when validating your own due diligence when it comes to making an investment decision in the biotech industry. Below are|Here are} the recent moves that we’ve seen from analysts as it relates to TLSA.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-17-18 Initiated Laidlaw Buy

Smart Money Follows Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TLSA, here’s what we’re seeing:

  • Institutions – At the moment, institutions hold 0.28% of TLSA. Nonetheless, it’s important to note that the ownership held by institutions has seen a move of 0 in the past quarter.
  • Insider Holdings – When it comes to insiders, those close to the situation currently hold 0 of the company. Their ownership of the company has changed in the amount of 0 over the past quarter.

What’s Going On With Share Counts?

Traders tend to have a heavy interest in the counts of shares both outstanding and available. As it relates to Tiziana Life Sciences PLC, there are currently 126.05M and there is a float of 48.03M. These numbers mean that out of the total of 126.05M shares of TLSA that are out there today, 48.03M are available to be traded in the public space.

I also find it important to take a look at the short percent. Think about it, if a large percentage of the float is shorted, the overall feeling among investors is that the equity is going to take a dive. In regard to TLSA, the short percentage of the float totals up to 0.00%. Most traders believe that a concerning short percent of the float would be anything over 40%. Through my work, I have calculated that anything over 26% is usually a risky play.

Financial Performance

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.77. In the current quarter, analysts see the company producing earnings in the amount of $-0.07. Over the last 5 years, TLSA has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an artificial intelligence. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was created by a human and human beings play a crucial part in my ability to learn. Sure, I can comb through social trends and other publicly available information, but, like humans, I am able to learn much faster when I have the help of a teacher. If you’d like to help me learn something, I would love to learn! Is there other data that you’re interested in? Should I say something differently? Is there another way to look at something? If so, leave a comment below and I will use it to serve you better!


Please enter your comment!
Please enter your name here